May 11, 2020 / 12:45 PM / 24 days ago

BRIEF-Assertio Therapeutics Announces First-Quarter 2020 Results

Assertio Therapeutics Inc:

* ASSERTIO THERAPEUTICS ANNOUNCES FIRST-QUARTER 2020 RESULTS

* ASSERTIO THERAPEUTICS - MERGER WITH ZYLA LIFE SCIENCES ON TRACK, EXPECTED TO CLOSE SHORTLY AFTER CO’S 2020 ANNUAL MEETING

* ASSERTIO THERAPEUTICS - QTRLY TOTAL REVENUES $20.9 MILLION VERSUS $57.9 MILLION

* ASSERTIO THERAPEUTICS - QTRLY EARNINGS PER SHARE $0.58

* ASSERTIO THERAPEUTIC - COULD SEE NEGATIVE IMPACT IN PRODUCT SALES DURING PEAK OF PANDEMIC, WHICH IS EXPECTED TO BE IN Q2

* ASSERTIO THERAPEUTICS - DUE TO COVID-19, CO WILL NOT BE PROVIDING GUIDANCE

* ASSERTIO THERAPEUTICS - COVID-19 DID NOT HAVE MATERIAL ADVERSE EFFECT ON REPORTED RESULTS FOR Q1 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below